Suman Lal

Suman Lal's work experience includes various roles in different companies. In 2016, Lal co-founded two startups, Cardiatrics, a digital health start-up focused on cardiovascular health, and Kyra, a personalized haircare start-up. Lal served as a co-founder for both companies until 2018.

In 2018, Lal became a mentor for the MIT Delta V Start-up Studio, where they helped MIT student entrepreneurs accelerate their growth in building viable ventures. Lal held this role until 2020.

In 2019, Lal became the COO and later the CEO of DeckTherapeutics, Inc., a company focused on developing therapeutic solutions. Lal served as CEO until December 2020.

Lal also worked as an Entrepreneur in Residence at Weill Cornell Medicine from 2019 to 2021, where they provided guidance and support to entrepreneurs in the biomedical field. Lal was also a mentor for Weill Cornell Medicine's BioVenture eLab program.

From 2020 to 2021, Lal worked as a strategic advisor for Solvuu, an advisory firm.

In 2021, Lal became the CEO of Culnexin Therapeutics, leading the development of small molecule therapeutics for precision oncology.

Lal founded Zero-to-One in 2021, focusing on entrepreneurship.

In 2022, Lal co-founded Neurochronix, Inc., and later joined CIC Captains of Innovation as a Senior Innovation Consultant and later as a Partner. CIC Captains of Innovation is an innovation consulting firm.

Overall, Suman Lal has a diverse background in entrepreneurship, innovation consulting, and biomedical research.

Suman Lal completed their education in a chronological order. They obtained an MBA degree from the Massachusetts Institute of Technology in the year 2014. Prior to that, they pursued a PhD in Oncology from the National University of Singapore from 2004 to 2009. They also completed an MSc in Molecular Genetics from the same university between 2001 and 2003. Suman Lal began their educational journey by achieving an MD degree in Medicine from Mahatma Gandhi University, spanning from 1993 to 1999.